Patent details

93169 Product Name: Lésinurad , ou un sel pharmaceutiquement acceptable de celui-ci

Basic Information

Publication number:
93169
Type:
SPC
SPC Type:
Medical
Basic Patent Number:
EP091707729
Legal Status:
Invalid
Application number:
93169
First applicant's nationality:
Procedural language:
French

Marketing Authorization

Marketing Authorization Number:
EU/1/15/1080 Zurampic/lesinurad
Marketing Authorization Type:
Marketing Authorization Date:
22/02/2016
Marketing Authorization Status:
Accepted
Marketing Authorization Country:

Dates

Filing date:
10/08/2016
First Marketing Authorization date:
22/02/2016
Grant date:
10/10/2016
Activation date:
Publication date:
10/10/2016
Lapsed date:
Expiration date:
Renunciation date:
Revocation date:
Annulment date:
Basic SPC Expiration:
25/08/2030
SPC Extension Expiration:
25/08/2030
Rejection date:
Withdrawal date:

Owner

From:
10/08/2016
 
 

Name:
ARDEA BIOSCIENCES, INC.
Address:
9390 TOWNE CENTRE DRIVE, SAN DIEGO, CALIFORNIA 92121, United States (US)

Agent

Name:
MARKS & CLERK LLP
From:
10/08/2016
Address:
BP 1775, 1017, LUXEMBOURG, Luxembourg (LU)
To:

Inventor

1

Name:
Girardet Jean-Luc
Address:
United States (US)

2

Name:
Koh Yung-Hyo
Address:
United States (US)

Annual Fees

Annual Fee Due Date:
Annual Fee Number:
Expected Payer:
Last Annual Fee Payment Date:
Last Annual Fee Paid Number:
Payer:
Filing date Document type Number of pages
12/08/2022 Request For Change 1
02/09/2022 Outgoing Correspondence 56